IMINOPHOSPHORANES
209
1
2
13C NMR (CDCl3): d ¼ 50.12 (d, JPC ¼ 123 Hz, C P), 58.37 (d, JPC ¼ 13 Hz, CH),
=
49.57, 52.73 (2 OCH3), 118.41, 121.26, 121.44, 125.92, 133.03, 153.08, 174.12 (7C
¼
benzothiazole), 129.66 (2JPC ¼ 12 Hz), 127.68 (d, JPC ¼ 92 Hz), 131.39 (d, JPC
1
4
3
2
ꢂ
=
3 Hz), 133.03 (d, JPC ¼ 10 Hz), 168.96 (d, JPC ¼ 12 Hz, C O), 171.08 (d,
JPC ¼ 12 Hz, C O). 31P NMR (CDCl3): d 22.45.
3
ꢂ
=
Minor isomer (40%). 1H NMR (CDCl3): d ¼ 2.94 (3H, s, OCH3), 3.53 (3H,
3
3
3
s, OCH3), 4.46 (1H, dd, JHP ¼ 5 Hz, JHH ¼ 10 Hz, P-C-CH), 6.86 (1H, d, JHH
¼
10 Hz, NH), 13C NMR (CDCl3): d ¼ 50.10 (d, JPC ¼ 123 Hz, C P), 58.42 (d,
1
=
2JPC ¼ 13 Hz, CH), 49.60, 52.69 (2 OCH3), 118.45, 121.20, 121.32, 125.87, 133.08,
153.12, 174.00 (7C benzothiazole), 129.45 (2JPC ¼ 12 Hz), 127.61 (d, JPC ¼ 92 Hz),
1
131.32 (d, JPC ¼ 3 Hz), 133.09 (d, JPC ¼ 10 Hz). 31P NMR (CDCl3): d 23.49.
4
3
Diethyl 2-(Thiazole-2-ylamino)-3-(triphenyl-k5-phosphanylidene)-
succinate (4c)
Yield: 95%; white powder; mp 168–170 ꢁC. IR (KBr) (nmax, cmꢀ1): 3386 (NH),
=
1748 (C O, ester). Calcd. for (C29H29N2O4PS): C, 65.40; H, 5.49; N, 5.26%. Found:
C, 65.51; H, 5.40; N, 5.18%. MS (m=z, %): 532 (M, 4).
Major isomer (75%). 1H NMR (CDCl3): d ¼ 1.23 and 1.35 (6H, 2 t
3
3JHH ¼ 7 Hz, 2 CH3), 3.36 and 4.25 (4H, 2q JHH ¼ 7 Hz, 2 OCH2), 4.62 (1H, dd,
3
3
3JHP ¼ 5 Hz, JHH ¼ 10 Hz, P-C-CH), 6.92 (1H, d, JHH ¼ 10 Hz, NH), 6.30 (1H, d,
3JHH ¼ 3.8 Hz, CH of C3H2NS), 6.77 (1H, d, JHH ¼ 3.8 Hz, CH of C3H2NS)
3
7.13–7.72 (15H, m, 3C6H5).ꢂ (ꢂFor two conformational isomers.) 13C NMR (CDCl3):
1
2
=
d ¼ 13.50 and 13.81 (2 CH3), 49.95 (d, JPC ¼ 123 Hz, C P), 57,76 (d, JPC ¼ 13 Hz,
CH), 62.07 and 62.31 (2 OCH2), 107.19, 138.87, 174.35 (3C C3H2NS), 127.16
¼
(d, JPC ¼ 92 Hz), 129.27 (2JPC ¼ 12 Hz), 132.47 (d, JPC ¼ 3 Hz), 134.07 (d, JPC
1
4
3
10 Hz). 168.89 (d, JPC ¼ 12 Hz, C O) , 171.32 (d, JPC ¼ 12 Hz, C O). 31P NMR
2
3
ꢂ
ꢂ
=
=
(CDCl3): d 22.75.
Minor isomer (25%). 1H NMR (CDCl3): d ¼ 1.17 and 1.33 (6H, 2 t
3
3JHH ¼ 7 Hz, 2 CH3), 3.52 and 4.20 (4H, 2q JHH ¼ 7 Hz, 2 OCH2), 4.69 (1H, dd,
3
3
3JHP ¼ 5 Hz, JHH ¼ 10 Hz, P-C-CH), 6.70 (1H, d, JHH ¼ 10 Hz, NH), 6.18 (1H, d,
3JHH ¼ 3.8 Hz, CH of C3H2NS), 6.79 (1H, d, JHH ¼ 3.8 Hz, CH of C3H2NS). 13C
3
1
=
NMR (CDCl3): d ¼ 13.52 and 13.78 (2 CH3), 49.90 (d, JPC ¼ 123 Hz, C P), 57.86
2
(d, JPC ¼ 13 Hz, CH), 62.01 and 62.16 (2 OCH2), 107.08, 138.94, 174.30 (3C
C3H2NS), 127.47 (d, JPC ¼ 92 Hz), 129.36 (2JPC ¼ 12 Hz), 132.56 (d, JPC ¼ 3 Hz),
1
4
134.23 (d, JPC ¼ 10 Hz). 31P NMR (CDCl3): d 22.83.
3
Diethyl 2-(Benzothiazole-2-ylamino)-3-(triphenyl-k5-phosphanylidene)-
succinate (4d)
Yield: 90%; white powder; mp 163–165 ꢁC. IR (KBr) (nmax, cmꢀ1): 3360 (NH),
=
1735 (C O, ester). Calcd. for (C33H31N2O4PS): C, 68.03; H, 5.36; N, 4.81%. Found:
C, 68.15; H,5.21; N, 4.77%. MS (m=z, %): 582 (M, 9).
Major isomer (70%). 1H NMR (CDCl3): d ¼ 1.20 and 1.42 (6H, 2 t
3
3JHH ¼ 7 Hz, 2 CH3), 3.47 and 4.18 (4H, 2q JHH ¼ 7 Hz, 2 OCH2), 4.69 (1H, dd,